We are live on
!
Find out more
CAM
Cresset Asset Management Portfolio holdings
AUM
$23.1B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+0.15%
1 Year Est. Return
+27.04%
3 Year Est. Return
+93.04%
5 Year Est. Return
+103.75%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$373M
(+5.3%)
Cap. Flow
+$381M
Cap. Flow
% of AUM
5.12%
Top 10 Holdings %
Top 10 Hldgs %
62.33%
Holding
1,161
New
145
Increased
742
Reduced
165
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARK Innovation ETF
ARKK
|
+$55.7M |
| 2 |
iShares Gold Trust
IAU
|
+$31.5M |
| 3 |
Hyatt Hotels
H
|
+$22.1M |
| 4 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$18M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$15.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$20.2M |
| 2 |
Celldex Therapeutics
CLDX
|
+$15.3M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$9.52M |
| 4 |
Palantir
PLTR
|
+$4.79M |
| 5 |
RTX Corp
RTX
|
+$4.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.28% |
| 2 | Consumer Discretionary | 6.79% |
| 3 | Healthcare | 3.4% |
| 4 | Financials | 3.36% |
| 5 | Communication Services | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $8.21M | 0.11% |
100,167
+32,772
| +49% | +$2.69M |
|
|
BSCM
77
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $8.17M | 0.11% |
379,640
-16,977
| -4% | -$366K |
|
78
Accenture
ACN
$108B
| $8.07M | 0.11% |
25,238
+1,691
| +7% | +$550K |
|
79
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $8.04M | 0.11% |
135,792
-1,768
| -1% | -$107K |
|
80
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
| $8.01M | 0.11% |
157,950
+129,806
| +461% | +$6.58M |
|
|
BSCN
81
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| $7.89M | 0.11% |
364,165
-6,346
| -2% | -$138K |
|
82
Chevron
CVX
$366B
| $7.84M | 0.11% |
77,263
+4,933
| +7% | +$492K |
|
|
SCHV
83
Schwab US Large-Cap Value ETF
SCHV
$16.1B
| $7.66M | 0.1% |
340,506
-16,668
| -5% | -$386K |
|
84
ExxonMobil
XOM
$634B
| $7.63M | 0.1% |
129,682
+24,901
| +24% | +$1.42M |
|
85
Coca-Cola
KO
$375B
| $7.34M | 0.1% |
138,764
+39,176
| +39% | +$2.18M |
|
86
Oracle
ORCL
$423B
| $7.28M | 0.1% |
83,583
-578
| -0.7% | -$51.1K |
|
87
Blackrock
BLK
$176B
| $7.25M | 0.1% |
8,646
+1,263
| +17% | +$1.13M |
|
88
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
| $7.25M | 0.1% |
163,750
+8,270
| +5% | +$382K |
|
89
iShares Russell 2000 ETF
IWM
$83B
| $7.14M | 0.1% |
32,630
+3,983
| +14% | +$883K |
|
90
Thermo Fisher Scientific
TMO
$220B
| $6.97M | 0.09% |
12,203
+1,733
| +17% | +$951K |
|
91
Netflix
NFLX
$309B
| $6.88M | 0.09% |
112,770
+7,770
| +7% | +$428K |
|
92
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
| $6.8M | 0.09% |
85,907
| – | – |
|
93
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
| $6.75M | 0.09% |
221,321
+5,473
| +3% | +$171K |
|
94
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $6.72M | 0.09% |
65,043
+841
| +1% | +$88.9K |
|
95
Amgen
AMGN
$222B
| $6.72M | 0.09% |
31,611
+3,216
| +11% | +$740K |
|
96
Verizon
VZ
$196B
| $6.53M | 0.09% |
120,819
-12,890
| -10% | -$713K |
|
97
Corning
GLW
$143B
| $6.48M | 0.09% |
177,568
+1,551
| +0.9% | +$61.9K |
|
98
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.6B
| $6.38M | 0.09% |
176,254
-1,523
| -0.9% | -$56.5K |
|
99
Intellia Therapeutics
NTLA
$1.67B
| $6.07M | 0.08% |
45,243
-4,161
| -8% | -$630K |
|
100
Target
TGT
$68B
| $6.01M | 0.08% |
26,271
+2,761
| +12% | +$692K |
|
Similar funds
CHP
FAM
OAG
BA
Cresset Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Cresset Asset Management held 1,161 positions worth $7.43B, up 5.3% from $7.06B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Cresset Asset Management deployed $381M of net new capital in Q3 2021, opening 145 new positions and adding to 742 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $20.2M trimmed.
- Cresset Asset Management's largest Q3 2021 buy was iShares MSCI USA Value Factor ETF: 173,351 shares worth $17.5M.
- Cresset Asset Management added most to ARK Innovation ETF in Q3 2021, an estimated $55.7M increase.
- Cresset Asset Management's biggest Q3 2021 reduction was Apple, cutting an estimated $20.2M.
- Cresset Asset Management fully exited Celldex Therapeutics in Q3 2021, selling an estimated $15.3M.
- Cresset Asset Management's ten largest holdings make up 62% of its $7.43B portfolio in Q3 2021.
- Cresset Asset Management opened 145 new positions and closed 58 in Q3 2021.
- Cresset Asset Management's portfolio value rose 5.3% quarter-over-quarter to $7.43B.
Based on Cresset Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.